Back
Fair Isaac 10K Form
Buy
84
FICO
Fair Isaac
Last Price:
2,308.94
Seasonality Move:
9.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-04-25 | 10Q | FICO/Fair Isaac Quarterly |
| 2024-01-25 | 10Q | FICO/Fair Isaac Quarterly |
| 2023-09-15 | 10Q | FICO/Fair Isaac Quarterly |
| 2023-08-02 | 10Q | FICO/Fair Isaac Quarterly |
| 2023-04-27 | 10Q | FICO/Fair Isaac Quarterly |
| 2023-01-26 | 10Q | FICO/Fair Isaac Quarterly |
Receive FICO News And Ratings
See the #1 stock for the next 7 days that we like better than FICO
FICO Financial Statistics
Sales & Book Value
| Annual Sales: | $1.72B |
|---|---|
| Cash Flow: | $219.36M |
| Price / Cash Flow: | 93.82 |
| Annual Sales: | $-39.47 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | 20.45000 |
|---|---|
| Net Income (TTM): | $512.81M |
| Gross Margin: | $1.37B |
| Return on Equity: | 0% |
| Return on Assets: | 30.9% |
Fair Isaac Earnings Forecast
Key Fair Isaac Financial Ratios
- The Gross Profit Margin over the past 39 years for FICO is 79.73%.
- The Selling, General & Administrative Expenses for FICO have been equal to 26.95% of Gross Profit Margin.
- The Research & Development expenses have been 10.01% of Revenue.
- The Interest Expense is 20.60% of Operating Income.
- The Net Earning history of FICO is 29.86% of Total Revenues.
- Per Share Earnings over the last 39 years have been positive in 26 years.
Fair Isaac Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Software |
| Sector: | Information Technology |
| Current Symbol: | FICO |
| CUSIP: | 303250 |
| Website: | fico.com |
Debt
| Debt-to-Equity Ratio: | -2.29 |
|---|---|
| Current Ratio: | 1.62 |
| Quick Ratio: | 1.52 |
Price-to-Earnings
| Trailing P/E Ratio: | 111.12 |
|---|---|
| Forward P/E Ratio: | 61.13 |
FICO Technical Analysis vs Fundamental Analysis
Buy
84
Fair Isaac (FICO)
is a Buy
Is Fair Isaac a Buy or a Sell?
-
Fair Isaac stock is rated a Buy
The current Fair Isaac [FICO] share price is $2,309.60. The Score for FICO is 84, which is 68% above its historic median score of 50, and infers lower risk than normal.